Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.22 USD | -4.40% | -17.27% | +57.23% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 137M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | 12.42M | Net Debt 2025 * | 19.19M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.2
x | P/E ratio 2025 * |
-6.6
x | Employees | 140 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.67% |
Latest transcript on Rani Therapeutics Holdings, Inc.
1 day | -4.40% | ||
1 week | -17.27% | ||
Current month | -18.18% | ||
1 month | -13.72% | ||
3 months | +52.19% | ||
6 months | +159.70% | ||
Current year | +57.23% |
Managers | Title | Age | Since |
---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 43 | 21-05-31 |
Mir Imran
FOU | Founder | 67 | 21-04-05 |
Svai Sanford
DFI | Director of Finance/CFO | 54 | 21-04-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laureen DeBuono
BRD | Director/Board Member | 66 | 21-04-05 |
Jean-Luc Butel
BRD | Director/Board Member | 67 | 21-04-05 |
Dennis Ausiello
BRD | Director/Board Member | 78 | 21-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.22 | -4.40% | 114,459 |
24-05-16 | 5.46 | -1.27% | 76,922 |
24-05-15 | 5.53 | -4.33% | 212,709 |
24-05-14 | 5.78 | -5.40% | 81,300 |
24-05-13 | 6.11 | -3.17% | 60,685 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.23% | 137M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- RANI Stock